(16) Basic and Diluted Net Loss Per Share

 

The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid in the fiscal years ended December 28, 2025, or December 29, 2024.

 

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts):

 

   Fiscal Year Ended 
   December 28,   December 29, 
   2025   2024 
Numerator for basic loss per share:        
Net loss from continuing operations  $(44,254)  $(54,444)
Net loss from discontinued operations   (1,100)   (2,007)
Net loss   (45,354)   (56,451)
Numerator for diluted loss per share          
Impact of September 2024 Notes derivative liability and interest expense, net of tax   
    (35,886)
Net loss  $(45,354)  $(92,337)
Denominator:          
Weighted average shares:          
Denominator for basic loss per share   87,108,928    66,655,837 
Effect of dilutive securities:          
September 2024 Notes derivative liability   
    9,137,711 
Denominator for diluted loss per share   87,108,928    75,793,548 
Net loss per share:          
Basic:          
Continuing operations  $(0.51)  $(0.82)
Discontinued operations   (0.01)   (0.03)
Net loss  $(0.52)  $(0.85)
Diluted          
Continuing operations  $(0.51)  $(1.19)
Discontinued operations   (0.01)   (0.03)
Net loss  $(0.52)  $(1.22)

 

The computation of basic net loss per share attributable to common stockholders is inclusive of warrants with an insignificant exercise price and the minimum number of shares to be issued in connection with the deferred consideration related to the Ambia acquisition. The Company’s calculation of the weighted average shares outstanding with an insignificant exercise price was 234,610 and 3,427,324 warrants (which assumes that the warrants were outstanding as of the beginning of the period or the date of the grant, whichever is earlier) for the fiscal years ended December 28, 2025, and December 29, 2024, respectively. The computation of diluted net loss per share attributable to common stockholders is inclusive of the impact of the Company’s September 2024 Notes (which were dilutive) using the if-converted method for the year ended December 29, 2024.

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:

 

   Fiscal Year Ended 
   December 28,   December 29, 
   2025   2024 
Common stock warrants   218,847    25,434,069 
Convertible notes   82,460,428    27,364,717 
Stock options and RSUs issued and outstanding   8,084,064    11,979,368 
Third SAFE Agreement   2,750,000    
 
Deferred consideration shares   11,640,506    
 
Potential common shares excluded from diluted net loss per share   105,153,845    64,778,154 

Historical Timeline

Fiscal YearFiled
2025Apr 14, 2026Showing above
2024Apr 30, 2025
2023Apr 1, 2024

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.